MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026

ConferenceVisiOmicsPositive

AI Analysis

Summary

MGI Tech launched VisiOmics, an AI-enabled pathology portfolio, in Europe and unveiled integrated tissue and molecular pathology solutions at ECP 2026. The platform offers multiplex immunofluorescence and sample-to-result sequencing capabilities powered by AI.

Importance:4/10

Sentiment:

0.60

Product LaunchEuropeAIPathologySequencingImmunofluorescenceECP 2026

Related Companies

$INBP $MOLN

Read the original article

Published by PR Newswire Biotech on September 15, 2026 7:24 AM

Read Original